NGM·Healthcare·$1.8B·#183 / 520 in Healthcare
ARDX Ardelyx, Inc.
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH35
QUALITY75
STABILITY48
VALUATION77
GOVERNANCE45
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+22.1%
35
> 50% strong
Gross Margin
Revenue retained after direct costs
90.3%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
19 months
69
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
124.6%
5
< 25% strong
Price / Sales
Market cap relative to trailing revenue
4.3x
77
< 3x strong
Rule of 40
Growth rate plus operating margin
12
38
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.2%
26
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+2.6%
84
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ARDX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ARDX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.